Literature DB >> 31186

The purification of a bovine kidney enzyme which cleaves melanocyte-stimulating hormone-release inhibiting factor.

M A Khilji, G S Bailey.   

Abstract

An enzyme which catalyzes the hydrolysis of L-prolyl-L-leucylglycinamide, the factor which inhibits the release of melanocyte-stimulating hormone, was purified 189-fold from bovine kidney in a 5% yield. The molecular weight of the enzyme on gel filtration was estimated to be 300 000 and its isoelectric point was found to be pH 4.1. The single component seen on sodium dodecyl sulphate-gel electrophoresis was estimated to have a molecular weight of 56 000, indicating that the native enzyme may be a pentamer or hexamer. The enzyme could clearly be distinguished from other prolyl-cleaving enzymes.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31186     DOI: 10.1016/0005-2744(78)90279-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Cloning, sequencing, and high expression of the proline iminopeptidase gene from Bacillus coagulans.

Authors:  A Kitazono; T Yoshimoto; D Tsuru
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

2.  Degradation of prolylleucylglycinamide (MIF) by mouse brain.

Authors:  A Neidle; N Yessaian; A Lajtha
Journal:  Neurochem Res       Date:  1980-09       Impact factor: 3.996

3.  Purification and characterization of a prolyl aminopeptidase from Debaryomyces hansenii.

Authors:  Tomás Bolumar; Yolanda Sanz; M-Concepción Aristoy; Fidel Toldrá
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

4.  Purification and characterization of ascamycin-hydrolysing aminopeptidase from Xanthomonas citri.

Authors:  H Osada; K Isono
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

Review 5.  Proline specific endo- and exopeptidases.

Authors:  R Walter; W H Simmons; T Yoshimoto
Journal:  Mol Cell Biochem       Date:  1980-04-18       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.